Matches in Nanopublications for { ?s ?p "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP373189.RA1AFe-NKew517dDVRiClP6MYQego8c2PKzIFTKy1G6ns130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373189.RA1AFe-NKew517dDVRiClP6MYQego8c2PKzIFTKy1G6ns130_provenance.
- NP182931.RABlRhHcZuOiwuQ-9dF2nr9kcIHAwYwihw3ZHXYEANOiI130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182931.RABlRhHcZuOiwuQ-9dF2nr9kcIHAwYwihw3ZHXYEANOiI130_provenance.
- assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP524495.RAZnz5Gw-4Ra_o5AdCAwxcMXchHQPmBSsFklDTnk_djTY130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524495.RAZnz5Gw-4Ra_o5AdCAwxcMXchHQPmBSsFklDTnk_djTY130_provenance.
- NP74772.RAnZHqV3vg4uiUH1Es28H2xlzhLtMDa1UoY0G1BiGrkgg130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74772.RAnZHqV3vg4uiUH1Es28H2xlzhLtMDa1UoY0G1BiGrkgg130_provenance.
- NP524767.RABWVxkv8f7_WshRBOxF-kwce6K9DHSpIIIngoGmH3mk8130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524767.RABWVxkv8f7_WshRBOxF-kwce6K9DHSpIIIngoGmH3mk8130_provenance.
- NP821052.RApXP2L-IA4efBmO12xohVl7qXkHZMGAsGoibPXE8WeaA130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821052.RApXP2L-IA4efBmO12xohVl7qXkHZMGAsGoibPXE8WeaA130_provenance.
- NP821054.RAuiJJiwYCK5cXPQdi_OY2ZwN_mAWNq551K2UzzLrt9Xs130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821054.RAuiJJiwYCK5cXPQdi_OY2ZwN_mAWNq551K2UzzLrt9Xs130_provenance.
- NP929452.RAJ8IzKi5q_WAi3b22vZFMcLqvHcNJ-wdi5inG8vf5tc4130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929452.RAJ8IzKi5q_WAi3b22vZFMcLqvHcNJ-wdi5inG8vf5tc4130_provenance.
- NP821053.RAEVYmWsSA03IOnZXQSnlAvcsLPhIXW9y7LKPZIIFpNvg130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821053.RAEVYmWsSA03IOnZXQSnlAvcsLPhIXW9y7LKPZIIFpNvg130_provenance.
- NP821050.RA1LcbBgxrANjWA0PfnHmY83B51hoS6z5YRu5VU_u5Ofw130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821050.RA1LcbBgxrANjWA0PfnHmY83B51hoS6z5YRu5VU_u5Ofw130_provenance.
- NP179447.RA9sBDcn-0g7q6u8Im3JQehVD9cyok0P1L_QalMTmSllQ130_assertion description "[Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179447.RA9sBDcn-0g7q6u8Im3JQehVD9cyok0P1L_QalMTmSllQ130_provenance.